Welcome to Arizona’s Bioscience Roadmap, a long-term strategic plan originally commissioned by the Flinn Foundation in 2002 and updated in 2014 with the goal of Arizona becoming globally competitive and a national leader in select areas of the biosciences by 2025.
- forming an entrepreneurial hub;
- turning research into practice;
- developing bio-talent;
- promoting Arizona’s convergence of research, health care, and commercialization to economic partners in neighboring states, Canada, and Mexico; and
- enhancing the state’s “collaborative gene” reputation.
Since the launch of the Roadmap, eight steps have been identified as priorities by Arizona’s Bioscience Roadmap Steering Committee. This group is comprised of more than 100 state leaders in science, business, economic development, academia, and government that meet quarterly to guide the Roadmap.
The updated plan was compiled by the Battelle Technology Partnership Practice based on research and input from Arizona science, business, academic and policy leaders as well as national bioscience experts. Battelle also produced the comprehensive study released in 2002 that found Arizona possessed many of the essential elements needed to become a global leader in niche areas in the biosciences, but must strengthen its biomedical-research base and build a critical mass of bioscience firms and jobs.
Throughout the Roadmap’s first decade, Battelle tracked performance data that was released annually by the Flinn Foundation. The performance metrics released in 2014 serve as the benchmark for the second decade of the Roadmap, with new data reported on a biennial basis. The most current data is available in “2015 Progress of the Biosciences in Arizona,” a report produced by TEConomy Partners (a spinoff of Battelle) that was released in March 2016. The Flinn Foundation will continue to track the progress of the bioscience sector each year by highlighting the state’s major developments. The most recent report is the “2016 Progress of the Biosciences in Arizona” released in April 2017 which calls for sustained investment in the biosciences and highlights the state’s most recent advancements.